Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–6 of 6 results
Advanced filters: Author: Judith Y. Altarejos Clear advanced filters
  • Myostatin and activin A are the two primary negative regulators of muscle mass. Blocking these circulating ligands during GLP-1 therapy induces improved body composition through preservation of lean mass and enhanced fat mass loss in obese primates.

    • Jason W. Mastaitis
    • Daniel Gomez
    • Mark W. Sleeman
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-8
  • Fat distribution is associated with cardiometabolic disease, although it has been less well studied than overall obesity. In a multiancestry exome-sequencing study, the authors identified predicted loss-of-function mutations in INHBE associated with favorable fat distribution and protection from type 2 diabetes.

    • Parsa Akbari
    • Olukayode A. Sosina
    • Luca A. Lotta
    ResearchOpen Access
    Nature Communications
    Volume: 13, P: 1-17
  • CRISPR-Cas9 is a gene editing tool that can be used to modulate gene expression. Here, the authors report the generation of a mouse model that express all components of the CRISPR-Cas9 guide directed Synergistic Activation Mediator (SAM), demonstrate that gene activation can be achieved with various delivery methods and include generation of a disease model of hypercholesterolemia

    • Charleen Hunt
    • Suzanne A. Hartford
    • Guochun Gong
    ResearchOpen Access
    Nature Communications
    Volume: 12, P: 1-14
  • β-adrenergic receptor signalling in adipocytes stimulates energy expenditure via cAMP-dependent increases in lipolysis and fatty-acid oxidation, and this signalling mechanism is thought to be disrupted in obesity. Here, the cAMP-responsive CREB coactivator Crtc3 is shown to promote obesity in mice by attenuating β adrenergic receptor signalling in adipose tissue.

    • Youngsup Song
    • Judith Altarejos
    • Marc Montminy
    Research
    Nature
    Volume: 468, P: 933-939
  • The cyclic AMP-responsive element-binding protein (CREB) is phosphorylated in response to a wide variety of signals, and it functions in concert with cAMP-regulated transcriptional co-activators (CRTCs). CREB and CRTCs mediate the effects of fasting and feeding signals on the expression of metabolic programmes in insulin-sensitive tissues.

    • Judith Y. Altarejos
    • Marc Montminy
    Reviews
    Nature Reviews Molecular Cell Biology
    Volume: 12, P: 141-151